Robot-assisted Level III-IV Inferior Vena Cava Thrombectomy: Initial Series with Step-by-step Procedures and 1-yr Outcomes

医学 四分位间距 围手术期 外科 下腔静脉 肝门 血栓
作者
Wei Wang,Qingbo Huang,Kan Liu,Fan Yang,Cheng Peng,Liangyou Gu,Taoping Shi,Peng Zhang,Wenzheng Chen,Songliang Du,Shaoxi Niu,Rong Liu,Guodong Zhao,Qiuyang Li,Xiao Chen,Rong Wang,Shuanglei Li,Maoqiang Wang,Fengyong Liu,Haiyi Wang,Hongzhao Li,Xin Ma,Xu Zhang
出处
期刊:European Urology [Elsevier]
卷期号:78 (1): 77-86 被引量:69
标识
DOI:10.1016/j.eururo.2019.04.019
摘要

Level III-IV robot-assisted inferior vena cava (IVC) thrombectomy (RA-IVCT) has been reported in limited series. To report our initial series of level III-IV RA-IVCT with step-by-step procedures and 1-yr outcomes. From November 2014 to January 2018, 13 patients with level III-IV IVC tumor thrombi underwent RA-IVCT with a minimum of 1-yr follow-up. Level III RA-IVCT requires liver mobilization and clamping of first porta hepatis (FPH), and suprahepatic and infradiaphragmatic IVC. Level IV RA-IVCT requires establishment of cardiopulmonary bypass (CPB). Thoracoscopy-assisted thrombectomy was performed for the intra-atrium part of the thrombus under CPB. Infradiaphragmatic RA-IVCT was completed in a manner similar to that of level III RA-IVCT. Detailed techniques were described for various scenarios. Baseline and perioperative outcomes were reported, and descriptive statistical analysis was performed. Median operative time was 465 (interquartile range [IQR]: 338–567) min. Median estimated intraoperative blood loss was 2000 (IQR: 1000–3000) ml. The rates of intraoperative blood transfusion and postoperative transformation to the intensive care unit ward were 92.3% and 100%, respectively. Median FPH blocking time was 40 (IQR: 25–60) min and the CPB time was 72 (IQR: 51–87) min. Three cases had grade IV complications, including two vascular injuries that were treated with intraoperative endoscopic sutures and one perioperative death. The perioperative mortality rate was 7.7%. During an 18-mo follow-up, two patients died and one patient progressed. Although the risks involved are high, level III-IV RA-IVCT is feasible and serves as an alternative minimally invasive method for selected patients. It also requires more complex techniques and multidisciplinary cooperation. We studied the treatment of patients with level III-IV inferior vena cava (IVC) tumor thrombi using a robotic approach. This technique was feasible for well-selected patients. However, level III-IV robot-assisted IVC thrombectomy requires more complex techniques and multidisciplinary cooperation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
义气珩发布了新的文献求助20
刚刚
暴躁的寻云完成签到 ,获得积分10
1秒前
2秒前
清风发布了新的文献求助10
4秒前
含蓄朋友完成签到,获得积分10
5秒前
脑洞疼应助TserJay采纳,获得10
6秒前
6秒前
7秒前
ExtroGod完成签到,获得积分10
7秒前
sars518应助wanzhen采纳,获得20
7秒前
Thhhh完成签到,获得积分10
8秒前
8秒前
传奇3应助sunny采纳,获得10
10秒前
10秒前
Whalen发布了新的文献求助10
11秒前
隐形曼青应助seven采纳,获得10
11秒前
GMR完成签到,获得积分20
11秒前
Cactus应助清风采纳,获得10
11秒前
12秒前
Daniel2010完成签到,获得积分10
12秒前
captain应助兔兔采纳,获得10
12秒前
12秒前
askd不渡神明完成签到,获得积分10
14秒前
langwang发布了新的文献求助10
15秒前
非非完成签到 ,获得积分10
15秒前
栀區发布了新的文献求助10
16秒前
星星完成签到,获得积分10
16秒前
17秒前
Maolin完成签到,获得积分10
17秒前
乐正秋凌完成签到,获得积分10
17秒前
xyj完成签到 ,获得积分10
17秒前
qaq完成签到,获得积分10
18秒前
Whalen完成签到,获得积分10
20秒前
MM发布了新的文献求助30
20秒前
RYu发布了新的文献求助10
21秒前
21秒前
WYYW完成签到,获得积分10
22秒前
栀區完成签到,获得积分10
22秒前
酸化土壤改良应助heart采纳,获得100
23秒前
23秒前
高分求助中
Deactivation and Catalyst Life Prediction of Ultra-Deep HDS Catalyst for Diesel Fractions 1000
Manual of Clinical Microbiology, 4 Volume Set (ASM Books) 13th Edition 1000
Sport in der Antike 800
Aspect and Predication: The Semantics of Argument Structure 666
De arte gymnastica. The art of gymnastics 600
少脉山油柑叶的化学成分研究 530
Electronic Structure Calculations and Structure-Property Relationships on Aromatic Nitro Compounds 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2413899
求助须知:如何正确求助?哪些是违规求助? 2107537
关于积分的说明 5327682
捐赠科研通 1834898
什么是DOI,文献DOI怎么找? 914259
版权声明 560994
科研通“疑难数据库(出版商)”最低求助积分说明 488839